We had the honour to see our latest article titled "What US trial sponsors should know about the GDPR" published in BioPharma Dive. In this article, we discuss what the GDPR is and why it matters to Life Sciences company. We also show how iliomad Health Data can help companies maintain GDPR compliance.
Link to the article :
https://www.biopharmadive.com/spons/what-us-trial-sponsors-should-know-about-the-gdpr/654291/
Sign up for our newsletter
We like to keep our readers up to date on complex regulatory issues, the latest industry trends and updated guidelines to help you to solve a problem or make an informed decision.
UK's NHS says hackers have published data stolen in ransomware attack
The UK's National Health Service (NHS) has confirmed that data stolen in a ransomware attack on Synnovis, a medical diagnostics service, has been published online, and the extent of the breach and its impact on patients is under investigation.
FTC Completes Updates to Health Breach Notification Rule for Health Apps
The Federal Trade Commission announced it has finalized changes to the Health Breach Notification Rule (HBNR) that will strengthen and modernize the rule by clarifying its applicability to health apps and other similar technologies and expanding the information that covered entities must provide to consumers when notifying them of a breach of their health data.
